Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,800,212
+$948,290 QoQ
Shares Held
149,664
-19.6% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#95
of 256 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OSAIC HOLDINGS, INC. holds $237,726,632 across 405 Biotechnology names. RLAY ranks #19 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
90,236 | $28,522,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,586 | $24,630,851 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
372,588 | $20,469,983 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
217,577 | $16,205,134 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
176,973 | $13,851,674 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
45,298 | $13,636,055 | |
| 7 | VCEL |
Vericel Corp
|
182,038 | $8,098,869 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,423 | $7,746,234 |
All Filings in RLAY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,800,212 | 149,664 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,851,922 | 186,123 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,576,841 | 186,388 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $972,944 | 186,388 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $6,618 | 1,913 | Shares | Defined | 2025-09-04 | |
| 2025-03-31 | $4,718 | 1,801 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $11,103 | 2,695 | Shares | Defined | 2025-06-06 | |
| 2024-09-30 | $167,328 | 23,634 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,229 | 342 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $202,295 | 24,373 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $266,783 | 24,231 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $204,169 | 24,277 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $305,107 | 24,292 | Shares | Defined | 2023-08-21 | |
| 2023-03-31 | $401,521 | 24,379 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $363,324 | 24,319 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $544,754 | 24,352 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $405,400 | 24,203 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $1,448,701 | 48,403 | Shares | Defined | 2022-05-04 | |
| 2021-12-31 | $1,486,456 | 48,403 | Shares | Defined | 2022-02-03 | |
| 2021-09-30 | $1,526,146 | 48,403 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $1,771,065 | 48,403 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $1,673,291 | 48,403 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||